Beneficient (NASDAQ:BENF – Get Free Report) released its quarterly earnings results on Monday. The company reported ($1.49) EPS for the quarter, missing the consensus estimate of $0.15 by ($1.64), Zacks reports.
Beneficient Stock Performance
BENF stock traded down $0.00 during trading on Monday, hitting $0.62. The stock had a trading volume of 51,153 shares, compared to its average volume of 3,046,668. The company’s 50 day moving average price is $1.03 and its two-hundred day moving average price is $2.85. Beneficient has a 1-year low of $0.50 and a 1-year high of $9.96. The stock has a market cap of $9.66 million, a price-to-earnings ratio of -0.09 and a beta of 0.05.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on BENF shares. Weiss Ratings restated a “sell (e+)” rating on shares of Beneficient in a research report on Monday, September 21st. Wall Street Zen upgraded Beneficient to a “hold” rating in a report on Saturday, October 24th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat, Beneficient currently has an average rating of “Sell”.
Read Our Latest Research Report on Beneficient
Beneficient Company Profile
Beneficient is a financial services company focused on providing liquidity and related services for investors in alternative assets, such as interests in private equity and other private funds. These investments can be difficult to sell, and the company’s services are intended to help holders access liquidity without waiting for a fund’s full life cycle to end. The company offers financing and transaction solutions for alternative-asset holders, alongside trust, custody, and administrative services.
Read More
- Five stocks we like better than Beneficient
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
